Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-23.36%
operating margin TTM
-23.39%
revenue TTM
3.26 Million
revenue per share TTM
0.04$
valuation ratios | |
|---|---|
| pe ratio | -7.35 |
| peg ratio | 0.78 |
| price to book ratio | 1.10 |
| price to sales ratio | 1.74 |
| enterprise value multiple | -14.58 |
| price fair value | 1.10 |
profitability ratios | |
|---|---|
| gross profit margin | 94.41% |
| operating profit margin | -23.39% |
| pretax profit margin | -21.79% |
| net profit margin | -23.36% |
| return on assets | -10.82% |
| return on equity | -13.44% |
| return on capital employed | -11.9% |
liquidity ratios | |
|---|---|
| current ratio | 6.25 |
| quick ratio | 6.25 |
| cash ratio | 2.52 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 1.56 |
| days of payables outstanding | 150.90 |
| cash conversion cycle | -149.34 |
| receivables turnover | 234.17 |
| payables turnover | 2.42 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.18 |
| debt equity ratio | 0.25 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.20 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -2.49 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.30 |
| cash per share | 1.54 |
| operating cash flow per share | -1.30 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -2.49 |
| short term coverage ratios | -29.70 |
| capital expenditure coverage ratio | -168.20 |
Frequently Asked Questions
When was the last time Century Therapeutics, Inc. (NASDAQ:IPSC) reported earnings?
Century Therapeutics, Inc. (IPSC) published its most recent earnings results on 13-11-2025.
What is Century Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Century Therapeutics, Inc. (NASDAQ:IPSC)'s trailing twelve months ROE is -13.44%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Century Therapeutics, Inc. (IPSC) currently has a ROA of -10.82%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IPSC's net profit margin stand at?
IPSC reported a profit margin of -23.36% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IPSC's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.25 in the most recent quarter. The quick ratio stood at 6.25, with a Debt/Eq ratio of 0.25.